FDA Inspection 667152 — Hexal AG
The FDA completed an inspection of Hexal AG on May 6, 2010 in Holzkirchen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 6, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Holzkirchen (Germany)